Lymphatic device tested for fibromyalgia relief
NCT ID NCT07201818
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a device called Lymphatic Enhancement Technology (LET) can reduce pain and improve quality of life in women with fibromyalgia. Forty participants will receive either active or sham LET treatments once a week for four weeks. Researchers will measure changes in symptoms using questionnaires and pain tests. The goal is to see if LET offers a new way to manage fibromyalgia symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UT Southwestern Medical Center in the Allied Health Physical Therapy Clinic
Dallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could hidden sleep problems be worsening fibromyalgia?
- Can a nerve zap in the neck tame fibromyalgia pain?
- Could a simple mineral calm the stress of fibromyalgia?
- Unlocking the genetic roots of fibromyalgia's pain puzzle
- Can a single ketamine infusion rewrite the story of fibromyalgia pain?
- Could a probiotic soothe fibromyalgia pain in young people?